Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Clinical trial NCT06633016 · RECRUITING
Trial details
- NCT number
- NCT06633016
- Sponsor
- Autobahn Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2026-06-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.